{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:58:01Z","timestamp":1781647081844,"version":"3.54.5"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":42,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100013412","name":"Sanofi Espa\u00f1a","doi-asserted-by":"publisher","award":["2019\/0081"],"award-info":[{"award-number":["2019\/0081"]}],"id":[{"id":"10.13039\/501100013412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Late-onset Pompe disease (LOPD) often leads to progressive respiratory failure due to diaphragmatic involvement. Conventional pulmonary function tests frequently fail to detect early respiratory muscle weakness. We conducted a five-year prospective cohort study of 15 genetically confirmed LOPD patients to evaluate diaphragmatic function using a multidimensional approach that included spirometry, inspiratory\/expiratory pressures (MIP\/MEP), sniff nasal inspiratory pressure (SNIP), arterial blood gases, and diaphragmatic ultrasound. Data were analyzed using generalized linear mixed models. Forced vital capacity (FVC) declined progressively (\u2212\u20091.05% per visit,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.010), while diaphragmatic thickening fraction (TF, \u2212\u20093.46% per visit,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.0001), SNIP (\u2212\u20092.53 cmH\u2082O per visit,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.003), and MIP (\u2212\u20093.56% per visit,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001) showed earlier and steeper declines. TF and SNIP were significantly more sensitive than FVC in detecting early respiratory involvement (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.05). Patients receiving enzyme replacement therapy (ERT) had slower functional decline, with significantly higher SNIP values (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.003). One patient developed symptomatic diaphragmatic weakness despite preserved FVC. SNIP and TF are more sensitive than FVC for early detection of respiratory dysfunction in LOPD and may allow earlier initiation of enzyme replacement therapy and respiratory support.\n                  <\/jats:p>","DOI":"10.1186\/s13023-026-04343-0","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T07:07:18Z","timestamp":1775545638000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Multidimensional assessment of diaphragmatic dysfunction in late-onset Pompe disease: a prospective cohort study"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0601-6954","authenticated-orcid":false,"given":"Ana","family":"Hern\u00e1ndez-Voth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2399-4370","authenticated-orcid":false,"given":"Javier","family":"Sayas-Catal\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0162-6649","authenticated-orcid":false,"given":"Marta","family":"Corral-Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3525-564X","authenticated-orcid":false,"given":"Miguel","family":"Jim\u00e9nez-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gema","family":"Carvajal-Cuesta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5151-988X","authenticated-orcid":false,"given":"Cristina","family":"Dom\u00ednguez-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8349-715X","authenticated-orcid":false,"given":"Laura","family":"Bermejo-Guerrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6892-3632","authenticated-orcid":false,"given":"Paloma","family":"Mart\u00edn-Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9772-423X","authenticated-orcid":false,"given":"Victoria","family":"Villena-Garrido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,7]]},"reference":[{"key":"4343_CR1","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.3390\/biom13091279","volume":"13","author":"B Labella","year":"2023","unstructured":"Labella B, Cotti Piccinelli S, Risi B, Caria F, Damioli S, Bertella E, et al. A Comprehensive Update on Late-Onset Pompe Disease. Biomolecules. 2023;13:1279. https:\/\/doi.org\/10.3390\/biom13091279.","journal-title":"Biomolecules"},{"key":"4343_CR2","doi-asserted-by":"publisher","first-page":"105277","DOI":"10.1016\/j.nmd.2025.105277","volume":"47","author":"M Porcino","year":"2025","unstructured":"Porcino M, Musumeci O, Usbergo C, Pugliese A, Arena IG, Rodolico C, et al. Management of presymptomatic juvenile patients with late-onset Pompe disease (LOPD). Neuromuscul Disord. 2025;47:105277. https:\/\/doi.org\/10.1016\/j.nmd.2025.105277.","journal-title":"Neuromuscul Disord"},{"key":"4343_CR3","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.braindev.2008.03.007","volume":"31","author":"S Nabatame","year":"2009","unstructured":"Nabatame S, Taniike M, Sakai N, Kato-Nishimura K, Mohri I, Kagitani-Shimono K, et al. Sleep disordered breathing in childhood-onset acid maltase deficiency. Brain Dev. 2009;31:234\u20139. https:\/\/doi.org\/10.1016\/j.braindev.2008.03.007.","journal-title":"Brain Dev"},{"key":"4343_CR4","doi-asserted-by":"publisher","first-page":"9419","DOI":"10.1073\/pnas.0902534106","volume":"106","author":"LR DeRuisseau","year":"2009","unstructured":"DeRuisseau LR, Fuller DD, Qiu K, DeRuisseau KC, Donnelly WH, Mah C, et al. Neural deficits contribute to respiratory insufficiency in Pompe disease. Proc Natl Acad Sci U S A. 2009;106:9419\u201324. https:\/\/doi.org\/10.1073\/pnas.0902534106.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4343_CR5","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1097\/00005072-197107000-00008","volume":"30","author":"P Gambetti","year":"1971","unstructured":"Gambetti P, DiMauro S, Baker L. Nervous system in Pompe\u2019s disease. Ultrastructure and biochemistry. J Neuropathol Exp Neurol. 1971;30:412\u201330. https:\/\/doi.org\/10.1097\/00005072-197107000-00008.","journal-title":"J Neuropathol Exp Neurol"},{"key":"4343_CR6","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1097\/00005072-196501000-00008","volume":"24","author":"EL Mancall","year":"1965","unstructured":"Mancall EL, Aponte GE, Berry RG, POMPE\u2019S DISEASE (DIFFUSE GLYCOGENOSIS) WITH NEURONAL STORAGE. J Neuropathol Exp Neurol. 1965;24:85\u201396. https:\/\/doi.org\/10.1097\/00005072-196501000-00008.","journal-title":"J Neuropathol Exp Neurol"},{"key":"4343_CR7","first-page":"379","volume":"27","author":"Y-T Teng","year":"2004","unstructured":"Teng Y-T, Su W-J, Hou J-W, Huang S-F. Infantile-onset glycogen storage disease type II (Pompe disease): report of a case with genetic diagnosis and pathological findings. Chang Gung Med J. 2004;27:379\u201384.","journal-title":"Chang Gung Med J"},{"key":"4343_CR8","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1038\/labinvest.3700484","volume":"86","author":"BL Thurberg","year":"2006","unstructured":"Thurberg BL, Lynch Maloney C, Vaccaro C, Afonso K, Tsai AC-H, Bossen E, et al. Characterization of pre- and post-treatment pathology after enzyme replacement therapy for Pompe disease. Lab Invest. 2006;86:1208\u201320. https:\/\/doi.org\/10.1038\/labinvest.3700484.","journal-title":"Lab Invest"},{"key":"4343_CR9","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1183\/09031936.00169011","volume":"39","author":"H Prigent","year":"2012","unstructured":"Prigent H, Orlikowski D, Lafor\u00eat P, Letilly N, Falaize L, Pellegrini N, et al. Supine volume drop and diaphragmatic function in adults with Pompe disease. Eur Respir J. 2012;39:1545\u20136. https:\/\/doi.org\/10.1183\/09031936.00169011.","journal-title":"Eur Respir J"},{"key":"4343_CR10","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/sj.mt.6300100","volume":"15","author":"C Mah","year":"2007","unstructured":"Mah C, Pacak CA, Cresawn KO, Deruisseau LR, Germain S, Lewis MA, et al. Physiological correction of Pompe disease by systemic delivery of adeno-associated virus serotype 1 vectors. Mol Ther. 2007;15:501\u20137. https:\/\/doi.org\/10.1038\/sj.mt.6300100.","journal-title":"Mol Ther"},{"key":"4343_CR11","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/mt.2009.305","volume":"18","author":"CS Mah","year":"2010","unstructured":"Mah CS, Falk DJ, Germain SA, Kelley JS, Lewis MA, Cloutier DA, et al. Gel-mediated delivery of AAV1 vectors corrects ventilatory function in Pompe mice with established disease. Mol Ther. 2010;18:502\u201310. https:\/\/doi.org\/10.1038\/mt.2009.305.","journal-title":"Mol Ther"},{"key":"4343_CR12","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1097\/GIM.0b013e3182142966","volume":"13","author":"D Forsha","year":"2011","unstructured":"Forsha D, Li JS, Smith PB, van der Ploeg AT, Kishnani P, Pasquali SK, et al. Cardiovascular abnormalities in late-onset Pompe disease and response to enzyme replacement therapy. Genet Med. 2011;13:625\u201331. https:\/\/doi.org\/10.1097\/GIM.0b013e3182142966.","journal-title":"Genet Med"},{"key":"4343_CR13","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1111\/j.1468-1331.2008.02377.x","volume":"16","author":"T Merk","year":"2009","unstructured":"Merk T, Wibmer T, Schumann C, Kr\u00fcger S. Glycogen storage disease type II (Pompe disease)--influence of enzyme replacement therapy in adults. Eur J Neurol. 2009;16:274\u20137. https:\/\/doi.org\/10.1111\/j.1468-1331.2008.02377.x.","journal-title":"Eur J Neurol"},{"key":"4343_CR14","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s10545-014-9751-2","volume":"38","author":"JC van der Meijden","year":"2015","unstructured":"van der Meijden JC, G\u00fcng\u00f6r D, Kruijshaar ME, Muir ADJ, Broekgaarden HA, van der Ploeg AT. Ten years of the international Pompe survey: patient reported outcomes as a reliable tool for studying treated and untreated children and adults with non-classic Pompe disease. J Inherit Metab Dis. 2015;38:495\u2013503. https:\/\/doi.org\/10.1007\/s10545-014-9751-2.","journal-title":"J Inherit Metab Dis"},{"key":"4343_CR15","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/1750-1172-8-49","volume":"8","author":"D G\u00fcng\u00f6r","year":"2013","unstructured":"G\u00fcng\u00f6r D, Kruijshaar ME, Plug I, D\u2019Agostino RB, Hagemans MLC, van Doorn PA, et al. Impact of enzyme replacement therapy on survival in adults with Pompe disease: results from a prospective international observational study. Orphanet J Rare Dis. 2013;8:49. https:\/\/doi.org\/10.1186\/1750-1172-8-49.","journal-title":"Orphanet J Rare Dis"},{"key":"4343_CR16","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1212\/01.wnl.0000198776.53007.2c","volume":"66","author":"MLC Hagemans","year":"2006","unstructured":"Hagemans MLC, Hop WJC, Van Doorn PA, Reuser AJJ, Van der Ploeg AT. Course of disability and respiratory function in untreated late-onset Pompe disease. Neurology. 2006;66:581\u20133. https:\/\/doi.org\/10.1212\/01.wnl.0000198776.53007.2c.","journal-title":"Neurology"},{"key":"4343_CR17","doi-asserted-by":"publisher","first-page":"713","DOI":"10.2147\/TCRM.S362871","volume":"19","author":"L El Haddad","year":"2023","unstructured":"El Haddad L, Khan M, Soufny R, Mummy D, Driehuys B, Mansour W, et al. Monitoring and Management of Respiratory Function in Pompe Disease: Current Perspectives. Ther Clin Risk Manag. 2023;19:713\u201329. https:\/\/doi.org\/10.2147\/TCRM.S362871.","journal-title":"Ther Clin Risk Manag"},{"key":"4343_CR18","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1097\/CND.0b013e318176dbe4","volume":"9","author":"LW Katzin","year":"2008","unstructured":"Katzin LW, Amato AA. Pompe disease: a review of the current diagnosis and treatment recommendations in the era of enzyme replacement therapy. J Clin Neuromuscul Dis. 2008;9:421\u201331. https:\/\/doi.org\/10.1097\/CND.0b013e318176dbe4.","journal-title":"J Clin Neuromuscul Dis"},{"key":"4343_CR19","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.arbres.2019.06.020","volume":"56","author":"J Sayas Catal\u00e1n","year":"2020","unstructured":"Sayas Catal\u00e1n J, Hern\u00e1ndez-Voth A, Villena Garrido MV. Diaphragmatic Ultrasound: An Innovative Tool Has Become Routine. Arch Bronconeumol (Engl Ed). 2020;56:201\u20133. https:\/\/doi.org\/10.1016\/j.arbres.2019.06.020.","journal-title":"Arch Bronconeumol (Engl Ed)"},{"key":"4343_CR20","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1186\/s13023-025-03981-0","volume":"20","author":"M Corbett","year":"2025","unstructured":"Corbett M, Umemneku-Chikere C, Nevitt S, Deng NJ, Walton M, Fulbright H, et al. Enzyme replacement therapy for the treatment of late onset Pompe disease: A systematic review and network meta-analysis. Orphanet J Rare Dis. 2025;20:451. https:\/\/doi.org\/10.1186\/s13023-025-03981-0.","journal-title":"Orphanet J Rare Dis"},{"key":"4343_CR21","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1136\/jmg.36.1.85","volume":"36","author":"R Hirschhorn","year":"1999","unstructured":"Hirschhorn R, Huie ML. Frequency of mutations for glycogen storage disease type II in different populations: the delta525T and deltaexon 18 mutations are not generally common in white populations. J Med Genet. 1999;36:85\u20136.","journal-title":"J Med Genet"},{"key":"4343_CR22","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1212\/01.WNL.0000158682.85052.C0","volume":"64","author":"U Mellies","year":"2005","unstructured":"Mellies U, Stehling F, Dohna-Schwake C, Ragette R, Teschler H, Voit T. Respiratory failure in Pompe disease: treatment with noninvasive ventilation. Neurology. 2005;64:1465\u20137. https:\/\/doi.org\/10.1212\/01.WNL.0000158682.85052.C0.","journal-title":"Neurology"},{"key":"4343_CR23","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1212\/wnl.55.8.1122","volume":"55","author":"P Lafor\u00eat","year":"2000","unstructured":"Lafor\u00eat P, Nicolino M, Eymard PB, Puech JP, Caillaud C, Poenaru L, et al. Juvenile and adult-onset acid maltase deficiency in France: genotype-phenotype correlation. Neurology. 2000;55:1122\u20138. https:\/\/doi.org\/10.1212\/wnl.55.8.1122.","journal-title":"Neurology"},{"key":"4343_CR24","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ymgme.2011.06.012","volume":"104","author":"Na van der Beek","year":"2011","unstructured":"van der Beek Na, van Capelle ME, van der Velden-van Etten CI, Hop KI, van den Berg WCJ, Reuser B. Rate of progression and predictive factors for pulmonary outcome in children and adults with Pompe disease. Mol Genet Metab. 2011;104:129\u201336. https:\/\/doi.org\/10.1016\/j.ymgme.2011.06.012.","journal-title":"Mol Genet Metab"},{"key":"4343_CR25","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1164\/rccm.200403-314OC","volume":"171","author":"RK Morgan","year":"2005","unstructured":"Morgan RK, McNally S, Alexander M, Conroy R, Hardiman O, Costello RW. Use of Sniff nasal-inspiratory force to predict survival in amyotrophic lateral sclerosis. Am J Respir Crit Care Med. 2005;171:269\u201374. https:\/\/doi.org\/10.1164\/rccm.200403-314OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"4343_CR26","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1080\/21678421.2025.2471421","volume":"26","author":"D Murray","year":"2025","unstructured":"Murray D, Rooney J, Meldrum D, Al-Chalabi A, Bunte TM, Chiwera T, et al. Respiratory measurements, respiratory symptoms, and quality of life in ALS: results from the REVEALS study. Amyotroph Lateral Scler Frontotemporal Degener. 2025;26:467\u201377. https:\/\/doi.org\/10.1080\/21678421.2025.2471421.","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"4343_CR27","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.sleep.2024.10.004","volume":"124","author":"M Y\u00fcksel Kalyoncu","year":"2024","unstructured":"Y\u00fcksel Kalyoncu M, Gokdemir Y, Yilmaz Yegit C, Yanaz M, Gulieva A, Selcuk M, et al. Can Sniff Nasal Inspiratory Pressure be a guide in detecting of sleep-disordered breathing in children with Duchenne Muscular Dystrophy? Sleep Med. 2024;124:662\u20138. https:\/\/doi.org\/10.1016\/j.sleep.2024.10.004.","journal-title":"Sleep Med"},{"key":"4343_CR28","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/s00134-013-2823-1","volume":"39","author":"D Matamis","year":"2013","unstructured":"Matamis D, Soilemezi E, Tsagourias M, Akoumianaki E, Dimassi S, Boroli F, et al. Sonographic evaluation of the diaphragm in critically ill patients. Technique and clinical applications. Intensive Care Med. 2013;39:801\u201310. https:\/\/doi.org\/10.1007\/s00134-013-2823-1.","journal-title":"Intensive Care Med"},{"key":"4343_CR29","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1378\/chest.07-2200","volume":"133","author":"EM Summerhill","year":"2008","unstructured":"Summerhill EM, El-Sameed YA, Glidden TJ, McCool FD. Monitoring recovery from diaphragm paralysis with ultrasound. Chest. 2008;133:737\u201343. https:\/\/doi.org\/10.1378\/chest.07-2200.","journal-title":"Chest"},{"key":"4343_CR30","doi-asserted-by":"publisher","first-page":"731865","DOI":"10.3389\/fneur.2021.731865","volume":"12","author":"J Spiesshoefer","year":"2021","unstructured":"Spiesshoefer J, Lutter R, Kabitz H-J, Henke C, Herkenrath S, Randerath W, et al. Respiratory Muscle Function Tests and Diaphragm Ultrasound Predict Nocturnal Hypoventilation in Slowly Progressive Myopathies. Front Neurol. 2021;12:731865. https:\/\/doi.org\/10.3389\/fneur.2021.731865.","journal-title":"Front Neurol"},{"key":"4343_CR31","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1007\/s00415-005-0922-9","volume":"252","author":"LPF Winkel","year":"2005","unstructured":"Winkel LPF, Hagemans MLC, van Doorn PA, Loonen MCB, Hop WJC, Reuser AJJ, et al. The natural course of non-classic Pompe\u2019s disease; a review of 225 published cases. J Neurol. 2005;252:875\u201384. https:\/\/doi.org\/10.1007\/s00415-005-0922-9.","journal-title":"J Neurol"},{"key":"4343_CR32","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1183\/09031936.05.00020005","volume":"26","author":"N Pellegrini","year":"2005","unstructured":"Pellegrini N, Laforet P, Orlikowski D, Pellegrini M, Caillaud C, Eymard B, et al. Respiratory insufficiency and limb muscle weakness in adults with Pompe\u2019s disease. Eur Respir J. 2005;26:1024\u201331. https:\/\/doi.org\/10.1183\/09031936.05.00020005.","journal-title":"Eur Respir J"},{"key":"4343_CR33","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.rmed.2008.12.009","volume":"103","author":"U Mellies","year":"2009","unstructured":"Mellies U, Lofaso F. Pompe disease: a neuromuscular disease with respiratory muscle involvement. Respir Med. 2009;103:477\u201384. https:\/\/doi.org\/10.1016\/j.rmed.2008.12.009.","journal-title":"Respir Med"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-026-04343-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04343-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04343-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:34:25Z","timestamp":1781645665000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13023-026-04343-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,7]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4343"],"URL":"https:\/\/doi.org\/10.1186\/s13023-026-04343-0","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,7]]},"assertion":[{"value":"12 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Medical Research Ethics Committee of the Fundaci\u00f3n para la Investigaci\u00f3n Biom\u00e9dica Hospital Universitario 12 de Octubre and the Instituto de Investigaci\u00f3n i\u2009+\u200912 (CEIm 19\/100, June 2019). The study was conducted in accordance with the Declaration of Helsinki, all participants provided written informed consent, and the report complies with the Journal\u2019s ethical publication guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval<!--Emphasis Type='Bold' removed-->and publication"}},{"value":"Artificial intelligence tools were used in the preparation of this manuscript for grammar correction and language refinement. All content was subsequently reviewed and validated by the authors to ensure accuracy and scientific integrity.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Artificial intelligence"}},{"value":"The authors declare having no conflicts of interest related to this publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"204"}}